These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38182556)

  • 21. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation.
    Bhatia N; Voelkel AJ; Hussain Z; Sharma UC; Slaughter MS; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):675-83. PubMed ID: 26366889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.
    Cagliostro B; Levin AP; Fried J; Stewart S; Parkis G; Mody KP; Garan AR; Topkara V; Takayama H; Naka Y; Jorde UP; Uriel N
    J Heart Lung Transplant; 2016 Jan; 35(1):108-114. PubMed ID: 26476767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Driveline Site Is Not a Predictor of Infection After Ventricular Assist Device Implantation.
    Martin BJ; Luc JGY; Maruyama M; MacArthur R; Bates AR; Buchholz H; Freed DH; Conway J
    ASAIO J; 2018; 64(5):616-622. PubMed ID: 29035899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices-5-year follow-up.
    Wert L; Hanke JS; Dogan G; Ricklefs M; Fleißner F; Chatterjee A; Feldmann C; Haverich A; Schmitto JD
    J Thorac Dis; 2018 Jun; 10(Suppl 15):S1703-S1710. PubMed ID: 30034842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple device to secure ventricular assist device driveline and prevent exit-site infection.
    Baronetto A; Centofanti P; Attisani M; Ricci D; Mussa B; Devotini R; Simonato E; Rinaldi M
    Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):415-7. PubMed ID: 24431003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.
    Camboni D; Zerdzitzki M; Hirt S; Tandler R; Weyand M; Schmid C
    Interact Cardiovasc Thorac Surg; 2017 Feb; 24(2):222-228. PubMed ID: 27702831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorbable antibiotic beads for treatment of LVAD driveline infections.
    Wadiwala I; Garg P; Alamouti-Fard E; Landolfo K; Sareyyupoglu B; Ahmed ME; Jacob S; Pham S
    Artif Organs; 2024 May; 48(5):559-566. PubMed ID: 38400624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Driveline infections in left ventricular assist devices: implications for destination therapy.
    Sharma V; Deo SV; Stulak JM; Durham LA; Daly RC; Park SJ; Baddour LM; Mehra K; Joyce LD
    Ann Thorac Surg; 2012 Nov; 94(5):1381-6. PubMed ID: 22818961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Polymyxin-Trimethoprim Prophylaxis May Decrease the Incidence of Driveline Infections in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Durand ML; Ennis SC; Baker JN; Camuso JM; McEachern KM; Kotton CN; Lewis GD; Garcia JP; MacGillivray TE
    Artif Organs; 2017 Feb; 41(2):169-175. PubMed ID: 27098102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricle assist devices and driveline's infection incidence: a single-centre experience.
    Bejko J; Toto F; Gregori D; Gerosa G; Bottio T
    J Artif Organs; 2018 Mar; 21(1):52-60. PubMed ID: 28988400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex HeartWare left ventricular assist device infection treated with pump exchange: clinical alert for the driveline location.
    Domae K; Toda K; Yoshioka D; Miyagawa S; Yoshikawa Y; Hata H; Kainuma S; Kawamura T; Kawamura A; Sawa Y
    J Artif Organs; 2021 Sep; 24(3):377-381. PubMed ID: 33439371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Gallium-SPECT-CT in the Management of Patients With Ventricular Assist Device-Specific Percutaneous Driveline Infection.
    Kimura Y; Seguchi O; Mochizuki H; Iwasaki K; Toda K; Kumai Y; Kuroda K; Nakajima S; Tateishi E; Watanabe T; Matsumoto Y; Fukushima S; Kiso K; Yanase M; Fujita T; Kobayashi J; Fukushima N
    J Card Fail; 2019 Oct; 25(10):795-802. PubMed ID: 31454687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Driveline Wound Care: Key to the Long-Term Use of Implantable Ventricular Assist Devices].
    Huang HC; Wang CH; Tsai FC
    Hu Li Za Zhi; 2019 Aug; 66(4):87-94. PubMed ID: 31342505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Driveline exit-site care protocols in patients with left ventricular assist devices: a systematic review.
    Koken ZO; Yalcin YC; van Netten D; de Bakker CC; van der Graaf M; Kervan U; Verkaik NJ; Caliskan K
    Eur J Cardiothorac Surg; 2021 Sep; 60(3):506-515. PubMed ID: 33963835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support.
    Imamura T; Kinugawa K; Nitta D; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Ono M
    J Artif Organs; 2015 Jun; 18(2):120-7. PubMed ID: 25604148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
    Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Driveline angle is crucial for preventing driveline infection in patients with HeartMate II device.
    Matsumoto Y; Fukushima S; Shimahara Y; Yamashita K; Kawamoto N; Kuroda K; Seguchi O; Yanase M; Fukushima N; Shimizu H; Kobayashi J; Fujita T
    J Artif Organs; 2019 Mar; 22(1):37-43. PubMed ID: 30298341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimum inhibitory concentration changes in relapsed left ventricular assist device driveline infections.
    Lines TH; Sabato LA; Nesbitt WJ; Moretz JD; Brinkley DM; Satyanarayana G
    Int J Artif Organs; 2020 Jul; 43(7):494-499. PubMed ID: 31964206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests.
    Kranzl M; Stoiber M; Schaefer AK; Riebandt J; Wiedemann D; Marko C; Laufer G; Zimpfer D; Schima H; Schlöglhofer T
    Front Cardiovasc Med; 2021; 8():784208. PubMed ID: 34977190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.